A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Learn more about:
Related Clinical Trial
A Prospective, Non-interventional (NIS), Long-term, Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Effects of GH and Lirglutide on AgRP
Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy
Impact of GH Measurements on GHD Diagnosis
Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin
Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™
Chromosome 18 Clinical Research Center
The Impact of the Use of Recombinant Human Growth Hormone on ADHD Characteristics in Children and Adolescents
Constructing an Insulin-Like Growth Factor-based Prediction Model
Peripheral Metabolic Effects of Somatostatin
The Effect of Dietary Fat Load and Physical Exercise on the Flexibility and Partitioning of Ectopic Lipids.
An Observational Study on Treatment Compliance by Children Treated With Growth Hormone
A Single Dose Trial in Growth Hormone Deficient Children Investigating Safety, Pharmacokinetics and Pharmacodynamics of Long Acting Growth Hormone
A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy Subjects
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)
A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
Safety and Efficacy of Long-term Somatropin Treatment in Adults
Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
Genotropin Study Assessing Use of Injection Pen
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
Treatment of Children With Insufficient Secretion of Growth Hormone
Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD
Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)
Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Inter-Assay Growth Hormone and IGF-I Variability
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
Easypod United States User Trial
National Cooperative Growth Study in CKD
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
Practicability and Acceptability of Stylomax® in Children
Growth Hormone’s Effect on the Cardiovascular System
Exploring Interactions Between Growth Hormone and the Microbiome
Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers
A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
Phase 1 Safety Study of ALRN-5281 in Healthy Subjects
Safety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
Growth Hormone and Chromosome 18q- and Abnormal Growth
An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®
Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects
A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
Study of TV-1106 in Growth Hormone-Deficient Adults
Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Long-Term Efficacy and Safety of Growth Hormone Replacement Therapy in Chronic Heart Failure
Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
Study of Pituitary Size and Function in Familial Dwarfism of Sindh
Adipocyte Function and Somtropin Deficiency
Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety
Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
Gene Expression in Monocytes of Growth Hormone Deficient Children
Sustained Release Formulation of Somatropin (rDNA Origin)for Injection
Molecular Basis of the Growth Axis in Short Stature
Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
The Effects of Growth Hormone (GH) on Lipid Depots
The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
Reference Values for Body Composition Parameters and IGF-I in the Adult NordiNet® International Outcome Study
Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
Metabolic Endocrinology and Growth Hormone in Adults
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
rhGH Therapy on Hepatic Drug Metabolism
Skeletal Muscle Effects of GH in Boys
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Adipose Tissue and Serum Inflammation in GH Deficiency
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy